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Regulation of Ins(3,4,5,6)P4 Signaling
by a Reversible Kinase/Phosphatase
with competing impacts. Ion channels provide particu-
larly impressive examples of the degree of signal amplifi-
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Ins(3,5,6)P3 (60  6 pA/pF, n 13) showed no inhibitoryRegulation of Cl channel conductance by
effect. These results indicate that no substantial InsP3Ins(3,4,5,6)P4 provides receptor-dependent control phosphorylation to Ins(3,4,5,6)P4 occurred, while alsoover salt and fluid secretion [1], cell volume homeosta-
demonstrating that all four phosphates of Ins(3,4,5,6)P4sis [2], and electrical excitability of neurones and
contribute to its exquisite specificity of action.smooth muscle [3]. Ignorance of how Ins(3,4,5,6)P4 is
We therefore turned to the alternate possibility thatsynthesized has long hindered our understanding of
Ins(3,4,5,6)P4 synthesis might involve dephosphoryla-this signaling pathway. We now show Ins(3,4,5,6)P4
tion of InsP5; the simplest, most direct route would besynthesis by Ins(1,3,4,5,6)P5 1-phosphatase activity
by direct 1-phosphatase attack on Ins(1,3,4,5,6)P5. Whileby an enzyme previously characterized [4] as an
cells possess active 3-phosphatase activity against thisIns(3,4,5,6)P4 1-kinase. Rationalization of these
Ins(1,3,4,5,6)P5 [13], a 1-phosphatase activity has neverphenomena with a ligand binding model unveils
been observed, even in tissues taken from 3-phospha-Ins(1,3,4)P3 as not simply an alternative kinase sub-
tase “knock-out” mice [13]. Thus, we speculated that ifstrate [4, 5], but also an activator of Ins(1,3,4,5,6)P5
a 1-phosphatase were to exist, we might only observe1-phosphatase. Stable overexpression of the enzyme
it in vitro under specialized assay conditions. Since, inin epithelial monolayers verifies its physiological role
principle, a phosphokinase may be reversible to somein elevating Ins(3,4,5,6)P4 levels and inhibiting secre-
degree if the ADP/ATP ratio is sufficiently high, wetion. It is exceptional for a single enzyme to catalyze
incubated the enzyme with 5 mM ADP, where-two opposing signaling reactions (1-kinase/1-phos-
upon [3H]Ins(1,3,4,5,6)P5 was dephosphorylated to anphatase) under physiological conditions. Reciprocal
[3H]InsP4 peak coeluting upon HPLC with a standard ofcoordination of these opposing reactions offers an
Ins(3,4,5,6)P4 (Figure 1A). Ins(1,4,5,6)P4 would also elutealternative to general doctrine that intracellular signals
at this point, but we eliminated this option, as theare regulated by integrating multiple, distinct phos-
[3H]InsP4 that was formed was a 1-kinase substrate (dataphatases and kinases [6].
not shown), which Ins(1,4,5,6)P4 is not [14]. Other poten-
tial products of InsP5 dephosphorylation were all ex-Results and Discussion
cluded by their earlier elution positions in this HPLC
system (Figures 1B and 1C). In addition, we discoveredSignaling entities are frequently controlled by quite deli-
cate shifts in the dynamic balance of regulatory signals (Figure 1B) that the Ins(1,3,4)P3 6-kinase activity of this
same enzyme [4] is also reversible. That is, Ins(1,3,4,6)P4
was dephosphorylated to Ins(1,3,4)P3 (Figure 1B).5 Correspondence: shears@niehs.nih.gov
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Figure 1. ADP-Dependent Dephosphorylation of Ins(1,3,4,5)P4, Ins(1,3,4,6)P4, and Ins(1,3,4,5,6)P5
Ins(3,4,5,6)P4 kinase (0.4 g) was incubated for 30 min in 100 l phosphatase assay buffer (see Experimental Procedures) either with (closed
circles) or without (open circles) 5 mM ADP plus trace amounts of either [3H]Ins(1,3,4,5,6)P5 (A) [3H]Ins(1,3,4,6)P4 (B), or [3H]Ins(1,3,4,5)P4 (C).
Samples were analyzed by HPLC (see Experimental Procedures). The elution positions of Ins(1,3,4)P3 and Ins(3,4,5,6)P4 were verified with
genuine standards. The elution positions of Ins(1,3,4,6)P4 (106 min, [B]) and of Ins(1,3,4,5)P4 (110 min, [C]) exclude these as products of InsP5
dephosphorylation (A).
However, these experiments also yielded several un- Ins(1,2,4)P3 is recognized as a mode 3 substrate.
Second, the ability of the kinase to phosphorylateexpected results. First, an additional, later-eluting InsP3
accumulated following Ins(1,3,4,6)P4 dephosphoryla- Ins(1,3,4)P3 at the 5 and 6 positions [4, 5, 18] is rational-
ized as reflecting two Ins(1,3,4)P3 binding modes (Figuretion, which is presumably Ins(3,4,6)P3 [not Ins(1,4,6)P3,
see below]. Second, the kinase yielded an identical pat- 2), rather than a 5,6-cyclic intermediate [5]. Our model
(Figure 2), which assumes a single active site, providestern of InsP3 products upon dephosphorylation of
[3H]Ins(1,3,4,5)P4 (Figure 1C), despite the latter not the simplest explanation for our data, but we do not
exclude more complex scenarios in which inositol phos-possessing a 6-phosphate. Third, Ins(1,3,4,6)P4 and
Ins(1,3,4,5)P4 were interconverted (Figures 1B and 1C). phates may bind to more than one site on the protein.
Assuming that our kinase/phosphatase utilizes a sin-Such “phosphomutase” activity is unprecedented in the
field of inositol phosphate metabolism. gle active site, there are two phosphate groups on the
inositol ring that are common to all binding modes andTo explain kinase reversibility and its phosphomutase
activity, we noted earlier studies [15], which were more may therefore be structural determinants for substrate
recognition (colored red in Figure 2). The position thatrecently applied to an inositol phosphate kinase from
yeast [16], showing that some inositol phosphates may is reversibly phosphorylated/dephosphorylated pre-
sumably also defines substrate recognition (also coloredinteract with binding sites of receptors and enzymes in
more than one orientation and that an inositol phosphate red in Figure 2). This model is consistent with other
data showing the enzyme does not phosphory-may mimic another by presenting key recognition fea-
tures to the site in certain binding orientations. We pro- late [3H]Ins(3,4)P2 (data not shown), nor Ins(1,3,4,5)P4,
Ins(1,3,4,6)P4, and Ins(1,4,5,6)P4 [14, 18]. While thepose a reaction pathway for the reversible kinase/phos-
phatase based on the idea that inositol phosphates bind groups colored red in Figure 2 are likely necessary for
substrate recognition, they cannot be sufficient, be-in three different orientations (shown as modes 1, 2, and
3 in Figure 2), including two modes for Ins(1,3,4)P3. This cause Ins(1,4)P2 itself is not phosphorylated (data not
shown). Therefore, other features of the inositol phos-new model (Figure 2) predicts that Ins(3,4,6)P3 is the
later-eluting InsP3 peak in Figures 1B and 1C and further phate ligands (colored green in Figure 2) must contribute
to recognition, and some of these additional interactionsprovides a novel explanation for two previously puzzling
observations. First, we recently showed but could not are, presumably, specific to certain binding modes.
The prediction that Ins(3,4,6)P3 is a type 1 substratesatisfactorily explain Ins(1,2,4)P3 phosphorylation by this
kinase at the 5 position [17]. Now we propose that (Figure 2) was verified (Figure 3) using an online mass
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Figure 3. HPLC Analysis of the Products of Ins(3,4,6)P3 Phosphory-
lation by the Ins(3,4,5,6)P4 Kinase
Ins(3,4,5,6)P4 kinase (3.4 g) was incubated in 200 l kinase assay
buffer for 0 (dotted trace) or 4 hr (solid trace) with 50 M Ins(3,4,6)P3
as described in Experimental Procedures. Samples were analyzed
by a mass detection HLPC technique (see Experimental Proce-
dures). The absorbance at the 30 min elution time was arbitrarily
set to zero. Elution positions of Ins(2,3,4,6)P4 and Ins(3,4,5,6)P4 are
shown. Identical results were obtained with a second, independently
synthesized source of Ins(3,4,6)P3 (see Experimental Procedures).
ADP ratio added to the incubation media. It is possible
that InsP4 participates more directly in the phosphotran-
sferase reactions. One way in which Ins(1,3,4)P3 could
be converted into Ins(1,3,4,6)P4 when Ins(1,3,4,5)P4 is
the original substrate (Figure 1C) would be forFigure 2. Proposed Kinase/Phosphatase Reaction Pathway
Ins(1,3,4,5)P4 to donate its 5-phosphate group to theThe schematic shows how three proposed substrate binding
enzyme, forming a phosphorylenzyme intermediate,modes for the enzyme are employed to permit interconversion
which then could transfer the phosphate to the 6-hydroxylof Ins(1,3,4)P3, Ins(3,4,6)P3, Ins(1,3,4,5)P4, and Ins(1,3,4,6)P4;
of Ins(1,3,4)P3, albeit in a manner apparently dependentIns(3,4,5,6)P4/Ins(1,3,4,5,6)P5 interconversion is also shown sepa-
rately. All of these inositol phosphates are shown bound to the upon some adenine nucleotide being present. Further-
enzyme (depicted as a reverse “L”), although the switch from one more, in incubations containing 5 M Ins(1,3,4,5,6)P5
binding mode to another may involve release and rebinding of an and 5 mM ADP, net accumulation of Ins(3,4,5,6)P4 wasinositol phosphate by the enzyme. If a single inositolphosphate bind-
increased by up to 5-fold upon addition of 1–5 Ming site is assumed, then the placement of certain hydroxyl and
Ins(1,3,4)P3 (Figure 4A). One explanation for this resultphosphate (“P”) groups (colored red) is equivalent in all three binding
is that the newly formed Ins(3,4,5,6)P4 can be rephos-modes. The group subject to reversible phosphorylation/dephos-
phorylation is highlighted in orange. phorylated, but less effectively in the presence of
Ins(1,3,4)P3, a competing kinase substrate [4]. Indeed,
in these experiments, there was net phosphorylation
of Ins(1,3,4)P3, but in a manner dependent upondetection HPLC technique [19, 20]. Kinetic data indicate
a Km of 0.2 M, a value close to that for Ins(1,3,4)P3 [4]. Ins(1,3,4,5,6)P5 (Figure 4B), which presumably donates
the phosphate group, via a phosphorylenzyme interme-We detected an InsP4 product eluting in the position
expected of Ins(1,3,4,6)P4 (Figure 3). Ins(1,3,4,5)P4 was diate, to either Ins(1,3,4)P3 or Ins(3,4,5,6)P4. Whatever
the explanation, our exploration of several unusual fea-also produced (Figure 3), although we cannot accurately
quantify the Ins(1,3,4,6)P4/Ins(1,3,4,5)P4 ratio; the signal tures of this enzyme have led us to uncover assay condi-
tions that optimize Ins(3,4,5,6)P4 synthesis (Figure 4A).strength of this HPLC technique is not proportional to
the number of phosphate groups [19] and even varies With Ins(1,3,4)P3 present, the Vmax for Ins(1,3,4,5,6)P5 de-
phosphorylation was 82 pmol/g protein/min, 10-foldconsiderably between isomers containing the same
number of phosphates [20]. Nevertheless, Ins(3,4,6)P3 less than the Vmax for Ins(3,4,5,6)P4 phosphorylation by
these same preparations of recombinant enzyme (datais clearly metabolized to Ins(1,3,4,5)P4 (Figure 3), consis-
tent with the reaction pathway shown in Figure 2. not shown and see [4]), although the latter reaction was
previously estimated to operate at only 5%–10% of itsThis involves dephosphorylation of Ins(1,3,4,6)P4 to
Ins(1,3,4)P3 even though ATP (and not ADP) was added capacity in receptor-activated cells [21].
Can this InsP5 1-phosphatase operate in vivo? Humanto these assays (Figures 2 and 3). Equally, the phosphor-
ylation of Ins(1,3,4)P3 to Ins(1,3,4,6)P4 occurs when ADP colonic epithelial T84 cells were stably transfected with
FLAG-tagged enzyme (theoretical size, 46.9 kDa). Ex-(and not ATP) was added to the assays (Figures 1C and
2). Thus, the ability of the enzyme to act as both a kinase pression was verified using anti-FLAG antibodies (Fig-
ure 5A, 49  0.3 kDa, n  3). Despite the enzyme act-and a phosphatase is not entirely dictated by the ATP/
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The enhancement of the receptor-initiated
Ins(3,4,5,6)P4 response in enzyme-transfected cells was
accompanied by a 40% reduction in Ca2-activated Cl
secretion (Figure 5D) from an intact cell monolayer. This
provides a unique validation of the signaling importance
of Ins(3,4,5,6)P4 in a physiological context. As well as
regulating salt and fluid secretion, these Ca2-activated
Clchannels mediate cell volume homeostasis and elec-
trical excitability in neurones and smooth muscle [3, 11],
which testifies to the wide-ranging biological impact of
our observations. Reciprocal coordination of the oppos-
ing 1-kinase/1-phosphatase reactions, catalyzed by a
single enzyme, offers an alternative to general doctrine
that intracellular signals are regulated by integrating
multiple phosphatases and kinases [6]. Finally, this dem-
onstration that the InsP5 1-phosphatase regulates secre-
tion (Figure 5) may also be of therapeutic interest. Upreg-
ulation of InsP5 1-phosphatase in airway epithelia could
inhibit the gob-5 chloride channel that drives mucus
secretion, which, when hyperresponsive, contributes to
the asthmatic condition [22]. Downregulation of InsP5
1-phosphatase could be used as a strategy for enhanc-
Figure 4. Ins(1,3,4)P3 Activates Ins(1,3,4,5,6)P5 1-Phosphatase Ac-
ing Cl secretion in the therapy of cystic fibrosis [3].tivity
Panel (A) shows the degree of 1-phosphatase activity toward 5 M
[3H]Ins(1,3,4,5,6)P5 in 15 min assays performed as described in the Experimental Procedures
legend to Figure 1; reactions were supplemented with either 0, 1,
or 5 M Ins(1,3,4)P3 plus 0.06 g enzyme (means  SE, n  5). Enzyme AssaysAdditional incubations were performed with 5 M [3H]Ins(1,3,4)P3
Inositol phosphate phosphatase activity was assayed in buffer con-(1200 d.p.m.) plus either no Ins(1,3,4,5,6)P5 (open circles) or 5
taining 100 mM KCl, 20 mM HEPES (pH 7.2), 5 mM ADP, 6 mMM nonradiolabeled Ins(1,3,4,5,6)P5 (closed circles); these reactions
MgSO4, 0.3 mg/ml bovine serum albumin. Assays were acidwere assayed by HPLC (Synchropak Q100 column), and the InsP4
quenched, neutralized, and analyzed by HPLC using a Synchropakregion of the chromatogram is shown in Panel (B).
Q100 column [14]; 1 ml fractions were collected for 70 min, followed
by 0.5 ml fractions. Inositol phosphate kinase activity was assayed
in buffer containing 100 mM KCl, 20 mM HEPES (pH 7.2), 5 mMing in vitro as both an Ins(3,4,5,6)P4 1-kinase and
ATP, 10 mM phosphocreatine, 6 mM MgSO4, 10 g/ml creatineIns(1,3,4,5,6)P5 1-phosphatase, the elevated levels of phosphokinase (Calbiochem), 0.3 mg/ml bovine serum albumin.
[3H]Ins(3,4,5,6)P4 in enzyme-transfected cells indicate Some assays were acid quenched and analyzed by HPLC using a
that phosphatase activity can predominate, specifically Synchropak Q100 column. Other reactions were heat inactivated
upon receptor activation (Figure 5B). Levels of [3H]InsP5 (95C, 3 min) and analyzed by a metal dye detection, HPLC method
[19, 20].were not significantly affected by transfection (Figure 5C).
Figure 5. Overexpression of InsP5 1-Phos-
phatase Activity in T84 Cells
(A) Western blotting of the FLAG epitope in
aliquots of cell lysates from vector (V, 20 l)
and enzyme (E, 10 l) transfected T84 cells.
Molecular weight markers are given. Panels
(B) and (C), respectively, show levels of
[3H]Ins(3,4,5,6)P4 and [3H]InsP5 in vector- and
enzyme-transfected T84 cells, prelabeled with
50 Ci [3H]inositol/ml for 4 days, and incu-
bated for 15 min with either vehicle or 100
M carbachol (CCh). Data were normalized
to the level of [3 H]PtdIns. The asterisk de-
notes that levels in vector-transfected cells
were significantly (p  0.02, n  4, paired t
test) lower than those in enzyme-transfected
cells. Panel (D) shows Cl secretion (assayed
as short-circuit current, ISC) across a T84
monolayer in response to 100 M carbachol
added to the basolateral surface. Data are
composite curves from 12 experiments with
vector- and enzyme-transfected cells.
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Transfection of the 1-Kinase/1-Phosphatase Gene A phosphoinositide-initiated signalling pathway that acts down-
stream of Ins(1,4,5)P3. In Frontiers in Molecular Biology: Biologyinto T84 Cells
T84 cells were cultured at 37C (5% CO2:95% air) in Iscove’s Modified of Phosphoinositides. S. Cockroft, ed. (Oxford: Oxford Univer-
sity Press), pp. 298–319.Dulbecco’s medium (Hyclone) supplemented with 5% (w/v) FBS
(Hyclone, Logan, UT), 100 U/ml penicillin, 0.1 mg/ml streptomycin, 4. Yang, X., and Shears, S.B. (2000). Multitasking in signal trans-
duction by a promiscuous human Ins(3,4,5,6)P4 1-kinase/and 0.8 mg/ml G418 selection agent. The gene previously denoted
a Ins(3,4,5,6)P4 1-kinase [4] was cloned into PCMV-Tag4 expression Ins(1,3,4)P3 5/6-kinase. Biochem. J. 351, 551–555.
5. Wilson, M.P., and Majerus, P.W. (1996). Isolation of inositolvector between the BamHI and XhoI sites after the stop codon was
removed. The transfection was carried out in a 60 mm dish, using 1,3,4-trisphosphate 5/6-kinase, cDNA cloning, and expression
of recombinant enzyme. J. Biol. Chem. 271, 11904–11910.LipoTAXI Mammalian Transfection Kit from Stratagene (La Jolla,
CA), according to the manufacturer’s instructions. Control transfec- 6. Woscholski, R., and Parker, P.J. (2000). Inositol phosphatases:
constructive destruction of phosphoinositides and inositoltions were performed at the same time using PCMV-Tag4 vector
alone. Data shown are from one pair of cell lines stably transfected phosphates. In Biology of Phosphoinositides, S. Cockroft, ed.
(Oxford: Oxford University Press), pp. 320–338.with either enzyme or vector; similar data were obtained with two
7. Clapham, D. (2001). How to lose your hippocampus by workingadditional, independently and stably transfected pairs of cell lines.
on chloride channels. Neuron 29, 1–6.
8. Ho, M.W.Y., Kaetzel, M.A., Armstrong, D.L., and Shears, S.B.Electrophysiology
(2001). Regulation of a human chloride channel: a paradigm forT84 cells were detached by incubation with 0.25% (w/v) trypsin/
integrating input from calcium, CaMKII and Ins(3,4,5,6)P4. J.0.02% (w/v) EDTA for 5–6 min. After trypsin removal, 200 l aliquots
Biol. Chem. 276, 18673–18680.(1.5  106/ml) were seeded into the circular wells (area  0.45 cm2)
9. Xie, W., Kaetzel, M.A., Bruzik, K.S., Dedman, J.R., Shears, S.B.,of permeable supports, made by gluing (Silastic sealant, Dow Corn-
and Nelson, D.J. (1996). Inositol 3,4,5,6-tetrakisphosphate inhib-ing, Midland, MI) a Sylgard ring to filters composed of mixed cellu-
its the calmodulin-dependent protein kinase II-activated chlo-lose esters (Millipore Corp., Bedford, MA). Seeded supports were
ride conductance in T84 colonic epithelial cells. J. Biol. Chem.floated on culture medium and incubated for 11–14 days before
271, 14092–14097.being mounted in modified Snapwell holders in Ussing chambers
10. Menniti, F.S., Oliver, K.G., Nogimori, K., Obie, J.F., Shears, S.B.,(EasyMount System, Physiologics Instruments, San Diego, CA).
and Putney, J.W., Jr. (1990). Origins of myo-inositol tetrakis-Transcellular Cl flux was then recorded as the short-circuit current
phosphates in agonist-stimulated rat pancreatoma cells. Stimu-as previously described [1]. The resistance of the monolayers were
lation by bombesin of myo-inositol (1,3,4,5,6) pentakisphos-(vector) 346  44 ohms/cm2 (mean  SE, n  12) and (kinase)
phate breakdown to myo-inositol (3,4,5,6) tetrakisphosphate. J.354  62 ohms/cm2 (mean  SE, n  12). Whole-cell Cl currents
Biol. Chem. 265, 11167–11176.in CFPAC-1 cells were measured at40mV as previously described,
11. Frings, S., Reuter, D., and Kleene, S.J. (2000). Neuronal Ca2-using an intracellular Ca2-BAPTA buffer to clamp free [Ca2] to
activated Cl channels—homing in on an elusive channel spe-0.5 M [8].
cies. Prog. Neurobiol. 60, 247–289.
12. Ho, M.W.Y., Shears, S.B., Bruzik, K.S., Duszyk, M., and French,Materials
A.S. (1997). Inositol 3,4,5,6-tetrakisphosphate specifically inhib-
American Type Cell Culture (Manassas, VA) supplied the CFPAC-1
its a receptor-mediated Ca2-dependent Cl current in
cells and T84 cells. Recombinant human Ins(3,4,5,6)P4 1-kinase was CFPAC-1 cells. Am. J. Physiol. 272, C1160–C1168.
expressed in E. coli and purified [4]. Nonradiolabeled Ins(1,3,4)P3 13. Chi, H., Yang, X., Kingsley, P.D., O’Keefe, R.J., Puzas, J.E.,
and Ins(1,3,4,5,6)P5 were purchased from CellSignals Inc (Lexington, Rosier, R.N., Shears, S.B., and Reynolds, P.R. (2000). Targeted
KY). The details of the synthesis of nonradiolabeled Ins(3,4,5)P3, deletion of Minpp1 provides new insight into the activity of
Ins(3,5,6)P3, Ins(4,5,6)P3, and Ins(3,4,6)P3 (as sodium salts) will be multiple inositol polyphosphate phosphatase in vivo. Mol. Cell.
published separately by S.-K.C. Ins(3,4,6)P3 was also prepared by Biol. 20, 6496–6507.
a different synthetic route [23]. [3H]Ins(1,3,4,5,6)P5 was prepared as 14. Caffrey, J.J., Darden, T., Wenk, M.R., and Shears, S.B. (2001).
previously described [24]. [3H]Ins(1,3,4)P3 was prepared from Expanding coincident signaling by PTEN through its Inositol
[3H]Ins(1,3,4,5)P4 (New England Nuclear), using recombinant 1,3,4,5,6-Pentakisphosphate 3-phosphatase Activity. FEBS
Ins(1,4,5)P3/Ins(1,3,4,5)P4 5-phosphatase [25]. [3 H]Ins(1,3,4)P3 was Lett. 499, 6–10.
converted to [3H]Ins(1,3,4,6)P4, using Ins(1,3,4)P3 6-kinase activity 15. Wilcox, R.A., Safrany, S.T., Lampe, D., Mills, S.J., Nahorski, S.R.,
[4]. [3H]Ins(3,4)P2 was prepared by alkaline phosphatase attack on and Potter, B.V.L. (1994). Modification at C2 of myo-inositol
[3H]Ins(1,3,4)P3 in 20 mM glycine (pH 9.0 with KOH). [3H]Ins(1,4)P2 1,4,5-trisphosphate produces inositol trisphosphates and tetra-
was purchased from New England Nuclear. kisphosphates with potent biological activities. Eur. J. Biochem.
223, 115–124.
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